Related Experiment Videos
Efficacy of biofeedback treatment compared with drug therapy in hypertensive patients
Insights
Biofeedback (BFB) effectively controls hypertension in selected patients by helping them regulate muscle contraction, peripheral temperature, and heart rate. This non-pharmacological approach shows promise for early-stage neurogenic hypertension management.
Area of Science:
- Cardiology
- Behavioral Medicine
- Hypertension Management
Background:
- Hypertension is a significant cardiovascular risk factor.
- Pharmacological treatments like diuretics and beta-blockers are common.
- Non-pharmacological interventions are sought for managing hypertension.
Purpose of the Study:
- To evaluate the efficacy of biofeedback (BFB) in controlling hypertension.
- To compare BFB with diuretic therapy, beta-blocker therapy, and no treatment.
- To assess BFB's potential in managing neurogenic hypertension.
Main Methods:
- 40 hypertensive patients were selected based on cardiovascular response to an arithmetic test.
- Patients were divided into four groups: diuretic therapy, beta-blocker therapy, BFB treatment, and no treatment.
- BFB treatment involved 36 sessions focusing on controlling muscular contraction, peripheral temperature, and heart rate via acoustic signals.
Main Results:
- Biofeedback treatment demonstrated significant reductions in systolic and diastolic blood pressure.
- Heart rate (HR) was also effectively reduced in the BFB group.
- Results suggest BFB is effective for selected hypertensive patients.
Conclusions:
- Biofeedback is an effective method for controlling hypertension in specific patient populations.
- BFB shows potential as an early-stage treatment for suspected neurogenic hypertension.
- This study supports the integration of BFB into hypertension management strategies.
Abstract:
To assess the ability of biofeedback (BFB) in controlling hypertension a study was made of 40 hypertensive patients selected by means of the cardiovascular response to an arithmetic test. The patients were divided into four treatment groups: 10 patients were treated with diuretic therapy (D-T), 10 with beta-blocker therapy (Bb-T), 10 with BFB treatment, while 10 had no treatment at all (N-T). The BFB treatment consisted of 36 sittings where patients were requested to control muscular contraction, peripheric temperature and heart rate (HR) by means of a correlated acoustic signal. The results for blood pressure and HR reductions were compared during a 12-month follow-up period. The results for systolic blood pressure, diastolic blood pressure and HR indicate the efficacy of BFB for selected patients and suggest the possibility of using BFB treatment in the first stages of suspected neurogenic hypertension.